{"id":"W4415099636","doi":"10.1016/j.parkreldis.2025.108077","title":"Development of composite scales for assessing disease progression and treatment effects among patients with Parkinson's disease in a clinical trial setting","year":2025,"lang":"en","type":"article","venue":"Parkinsonism & Related Disorders","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Broadcom (Canada)","funders":"Avid Radiopharmaceuticals; Allergan; Genentech; H. Lundbeck A/S; Servier; Sun Pharma; Voyager Therapeutics; Neurocrine Biosciences; Biogen; Celgene; Parkinson's UK; Jazz Pharmaceuticals; Verily Life Sciences; Teva Pharmaceutical Industries; Sanofi; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company","keywords":"Clinical trial; Disease; Clinical disease; MEDLINE; Severity of illness","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08552651,0.001180882,0.003465783,0.003616795,0.001346885,0.002972006,0.001408244,0.0009549009,0.002496598],"category_scores_gemma":[0.09609382,0.0005827953,0.004682269,0.003392012,0.0006988738,0.002815009,0.002302862,0.002661457,0.0004937641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002073919,"about_ca_system_score_gemma":0.004637387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001206022,"about_ca_topic_score_gemma":0.003753589,"domain_scores_codex":[0.9346847,0.04440765,0.008732785,0.001713704,0.009497465,0.0009637653],"domain_scores_gemma":[0.8889049,0.0635118,0.0240159,0.004578197,0.01561649,0.003372749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.07051932,0.009010385,0.559756,0.004607058,0.01445982,0.0001494831,0.001617872,0.007029723,0.002368958,0.00412782,0.0143513,0.3120022],"study_design_scores_gemma":[0.02090777,0.05060246,0.8744194,0.0009558666,0.005351326,0.0003705776,0.001243645,0.0230666,0.002929368,0.005187125,0.01461855,0.0003472914],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.8308289,0.007577569,0.0685125,0.001783336,0.001123807,0.05355967,0.01364981,0.0007896287,0.02217476],"genre_scores_gemma":[0.8298658,0.001427995,0.1037551,0.0006274447,0.0001990469,0.05537002,0.007443179,0.000111056,0.001200302],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.08552651,"threshold_uncertainty_score":0.4523128,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01121427878961918,"score_gpt":0.3131627362027787,"score_spread":0.3019484574131595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}